Searchable abstracts of presentations at key conferences in endocrinology

ea0021p337 | Steroids | SFEBES2009

Determination of tandem mass spectrometry specific reference ranges for testosterone, androstenedione and DHEAS

Macdonald Philip , Wu Frederick , Owen Laura , Keevil Brian

Testosterone, androstenedione and DHEAS are commonly measured by immunoassays. Variations in antibody specificity and calibration of assays results in non-commutability of measurements. Even more specific mass spectrometry (LC–MS/MS) assays still exhibit differences in calibration. As the use of mass spectrometry for measuring steroids is becoming more common in the clinical laboratory, the development of LC–MS/MS reference ranges for these analytes is essential to h...

ea0021p347 | Steroids | SFEBES2009

Regulation of glucocorticoid receptor activity by cellular stress

Davies Laura , Sadeq Malihah , Demonacos Constantinos , Krstic-Demonacos Marija

Cofactors of the nuclear hormone receptors are crucial in regulating their transcriptional activity. The glucocorticoid receptor (GR) is a member of the nuclear hormone receptor superfamily, involved in the regulation of metabolism, inflammation and stress–responses and many GR cofactors are known, including p300. Here, we identify a new cofactor for GR: TTC5/Strap, tetratricopeptide repeat domain 5/ stress–responsive activator of p300. Strap is a TPR motif containin...

ea0019p335 | Steroids | SFEBES2009

Epigenetic silencing of the GR and defining the pro-apoptotic actions of GR expression in human cancer cell lines

Kay Paul , Matthews Laura , Sommer Paula , White Anne , Ray David

Although glucocorticoids (Gc) are used to treat a range of pathologies, an individuals response to therapy varies considerably. There is a distinct correlation between certain cell types and steroid sensitivity. Aberrant glucocorticoid receptor (GR) function is well-characterised in lymphoid malignant cells but not small cell lung cancer (SCLC) (DMS79) or osteosarcoma (U2OS) cell lines, which are both Gc resistant.Previously we have shown reduced GR cont...

ea0016p141 | Clinical cases | ECE2008

Monogenic form of polycystic ovary syndrome due to mutation in lamin A/C gene: case report of two sisters

Forlani Giulia , Gambineri Alessandra , Patton Laura , Pagotto Uberto , Pasquali Renato

We report of two sisters with hyperandrogenism, menstrual abnormalities, and severe insulin resistance. The elder sister was seen after puberty at age 21 and she was referred for the evaluation of hirsutism and polymenorrhoea; the younger was seen earlier in life, at age 15, for the evaluation of secondary amenorrhoea. In both of them, we performed the diagnosis of polycystic ovary syndrome (PCOS) in accordance to the Rotterdam criteria. They also presented a lipodystrophic ph...

ea0015oc4 | Young Endocrinologist prize session | SFEBES2008

Hypoxia and GC Signalling regulate macrophage migration inhibitory factor (mif) gene expression through a common element

Elsby Laura , Donn Rachelle , Alourfi Zaynab , Beaulieu Elaine , Ray David

MIF is a potent pro-inflammatory mediator that opposes the anti-inflammatory actions of glucocorticoids (Gc) and is involved in the pathogenesis of multiple diseases. The MIF promoter is inhibited by Gc in lymphocytes (CEMC7A) but not in epithelial cells (A549), despite expression of functional glucocorticoid receptors (GR) in both. Deletion studies localized the cis element responsible for Gc inhibition to between MIF −71 and +85. This sequence contained no GR binding s...

ea0015oc28 | Pituitary, disease | SFEBES2008

Pre-receptor cortisol metabolism is a critical regulator of insulin signalling in human adipose tissue

Gathercole Laura , Bujalska Iwona , Stewart Paul , Tomlinson Jeremy

Glucocorticoid (GC) excess is characterized by central obesity, insulin resistance and in some cases, type 2 diabetes mellitus. Whilst it is accepted that GCs cause insulin resistance, both insulin and GCs act synergistically to promote adipocyte differentiation. We have previously shown that acute treatment (24 h) with GCs enhances insulin signalling in human adipocytes. We hypothesise that the generation of cortisol from inactive cortisone by 11β-hydroxysteroid dehydrog...

ea0015p63 | Clinical practice/governance and case reports | SFEBES2008

Specialist obesity services: are we seeing the right patients?

Flutter Laura , Faghahati Leila , Palin Suzzane , Tahrani Abd , Rahim Asad

Background: Obesity levels and the demand for obesity services are increasing. Those with morbid obesity require specialist care and consideration for bariatric surgery. Based on recent figures and NICE guidelines, at least 35 000 individuals in Birmingham alone may be suitable for surgery. Numbers currently assessed are limited due to lack of resource and expertise. This audit reviewed baseline characteristics of patients referred for specialist obesity and bariatric services...

ea0015p153 | Diabetes, metabolism and cardiovascular | SFEBES2008

Depot specific differences in lipogenesis in human adipose tissue

Gathercole Laura , Bujalska Iwona , Stewart Paul , Tomlinson Jeremy

Intra-abdominal adiposity is associated with insulin resistance and increased cardiovascular morbidity and mortality. Obesity occurs as a consequence of increased adipocyte size (hypertrophy) and number (differentiation or hyperplasia). Whilst differences in gene expression between omental (om) and subcutaneous (sc) adipose tissue have been described, the molecular mechanisms that underpin the differences in adipose tissue biology and the depot specific metabolic risks that th...

ea0015p154 | Diabetes, metabolism and cardiovascular | SFEBES2008

Dehydroepiandrosterone exerts anti-glucocorticoid action on proliferation, differentiation and insulin sensitivity in human preadipocytes

McNelis Joanne , Gathercole Laura , Stewart Paul , Tomlinson Jeremy , Arlt Wiebke

The adrenal steroid dehydroepiandrosterone (DHEA) and its sulphate ester, DHEAS have been shown to oppose the effects of glucocorticoids, thereby producing beneficial effects on insulin sensitivity in rodent models of diabetes and obesity and in hypoadrenal patients. Glucocorticoids, key regulators of adipose differentiation and insulin sensitivity, are reactivated locally by 11β-hydroxysteroid dehydrogenase type (11β-HSD1) oxoreductase activity, which increases with...

ea0015p313 | Steroids | SFEBES2008

Measurement of salivary cortisol with LC-MS/MS in patients with suspected adrenal pathology

Perogamvros Ilias , Keevil Brian , Owen Laura , Trainer Peter , Brabant Georg

Salivary cortisol (SalC) potentially has advantages over serum cortisol (SerC) as it is easier to collect and possibly reflects unbound (free) cortisol. SalC levels are approximately 10 times lower than SerC and require high measurement precision best addressed by liquid chromatography–tandem mass spectrometry (LC-MS/MS), which in contrast to previously used radioimmunoassays eliminates cross-reactivity by other steroids. We describe the use of LC-MS/MS to evaluate the po...